2020
DOI: 10.1016/j.hoc.2020.01.001
|View full text |Cite
|
Sign up to set email alerts
|

Blastic Plasmacytoid Dendritic Cell Neoplasm

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(12 citation statements)
references
References 31 publications
0
12
0
Order By: Relevance
“…Plasmacytoid dendritic cells comprise less than 0.5% of circulating mononuclear cells and are classically found in lymph nodes and tonsils [6]. They are absent in healthy skin, but in certain dermatological conditions such as contact dermatitis and lupus erythematosus, they are recruited to the skin where they secrete massive amounts of IFN1, IFNalpha, and IFNbeta [2].…”
Section: Case Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Plasmacytoid dendritic cells comprise less than 0.5% of circulating mononuclear cells and are classically found in lymph nodes and tonsils [6]. They are absent in healthy skin, but in certain dermatological conditions such as contact dermatitis and lupus erythematosus, they are recruited to the skin where they secrete massive amounts of IFN1, IFNalpha, and IFNbeta [2].…”
Section: Case Discussionmentioning
confidence: 99%
“…The presentation of this disorder is highly heterogenous and has a high frequency of cutaneous and bone marrow involvement [1]. Skin manifestations are often the first symptoms that cause a patient to seek medical care and these can precede leukemic spread [1,2]. Dermatological presentations vary between bruise-like macules to isolated violaceous nodules and may be limited and focal or diffuse [3].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…The bruise-like infiltrates lesions, most characteristic for BPDCN, could be an early manifestation of neoplastic cell infiltration with red blood cell extravasation in the skin. 14 The Modified Skin Weighted Assessment Tool (mSWAT) can be used to estimate and monitor the extent and severity of cutaneous disease. 15 …”
Section: Clinical Presentationmentioning
confidence: 99%